Detalles de la búsqueda
1.
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
Lung
; 202(2): 197-210, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480620
2.
Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity.
Int J Mol Sci
; 25(1)2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38203395
3.
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
Int J Mol Sci
; 22(5)2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33807876
4.
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study.
Br J Cancer
; 122(11): 1611-1617, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32231293
5.
Gonadotropin Releasing Hormone Agonists Have an Anti-apoptotic Effect on Cumulus Cells.
Int J Mol Sci
; 20(23)2019 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31801245
6.
Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectives.
Anticancer Drugs
; 27(10): 917-43, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27400375
7.
Immunotherapy for genitourinary cancer: state of the art and new perspectives.
Anticancer Drugs
; 27(7): 585-99, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27183027
8.
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.
Tumori
; 110(3): 168-173, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372045
9.
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Cells
; 12(6)2023 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980174
10.
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center.
Heliyon
; 9(11): e21177, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37928020
11.
Novel approaches for the treatment of unresectable malignant pleural mesothelioma: A focus on immunotherapy and target therapy (Review).
Mol Clin Oncol
; 16(4): 89, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35251640
12.
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives.
Expert Opin Biol Ther
; 22(10): 1259-1273, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35994596
13.
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy.
Cancers (Basel)
; 14(20)2022 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291830
14.
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.
Cancers (Basel)
; 14(14)2022 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884472
15.
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade.
Front Immunol
; 12: 799455, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35069581
16.
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populations.
Immunotherapy
; 13(6): 509-525, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33626932
17.
New emerging targets in cancer immunotherapy: the role of GITR.
ESMO Open
; 4(Suppl 3): e000738, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32817129
18.
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient.
Cancers (Basel)
; 12(5)2020 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32365882
19.
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study.
Clin Breast Cancer
; 20(2): e181-e187, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31735691
20.
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review.
Clin Med Insights Reprod Health
; 13: 1179558119864584, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31391786